Current and future pharmacotherapy for treating overactive bladder.
about
CUA guideline on adult overactive bladderExpected Next-Generation Drugs Under Development in Relation to Voiding SymptomsSafety issues associated with using medication to treat overactive bladder.Inhibition of salivary secretion by tolterodine transdermal patch.Muscarinic receptor-induced contractions of the detrusor are impaired in TRPC4 deficient mice.
P2860
Current and future pharmacotherapy for treating overactive bladder.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Current and future pharmacotherapy for treating overactive bladder.
@en
type
label
Current and future pharmacotherapy for treating overactive bladder.
@en
prefLabel
Current and future pharmacotherapy for treating overactive bladder.
@en
P2860
P1476
Current and future pharmacotherapy for treating overactive bladder.
@en
P2093
Dudley Robinson
Linda Cardozo
P2860
P304
P356
10.1080/14656566.2016.1186645
P407
P577
2016-06-02T00:00:00Z